EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal
Aspire Biopharma (NASDAQ: ASBP) completes $30M cash acquisition of Dura Driver Control Systems, adding $200M+ in annual revenue.
Read original at benzingaStocks · News reference
Aspire Biopharma Stock Is Sliding Today: What's Going On?
Aspire Biopharma Holdings Inc. (NASDAQ: ASBP) shares initially surged on Friday but have since reversed. Here's what you need to know.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jun 12, 2026, 2:11 PM
- Checked
- Jun 12, 2026, 2:15 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
EXCLUSIVE: Aspire Biopharma Completes Dura Driver Control Systems Acquisition, Automotive Supplier with Over $200M 2025 Revenue; Expects Improved Path To Profitability
Read original at benzingaAspire Biopharma to Present at the Life Sciences Investor Forum on June 25th
Aspire Biopharma Holdings (ASBP) announced it will present live at the Life Sciences Investor Forum on June 25th, 2026. The company highlighted its multiple prescription applications in cardiovascular and other therapeutic areas, its lead drug candidate high-dose aspirin product, and the commercial launch of BUZZ BOMB caffeine product. Aspire also announced a proposed acquisition of Dura Driver Control Systems, expected to close in Q3 2026.
Read original at globenewswire-inc